AEGiS-AP: Mylan says FDA approved generic of HIV drug Zerit Associated PressImportant note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu




DonateNow



Mylan says FDA approved generic of HIV drug Zerit

Associated Press - December 30, 2008

PITTSBURGH (AP) -- Mylan Inc. said Tuesday it has started selling a generic version of Bristol-Myers Squibb Co.'s HIV drug Zerit after receiving approval from the Food and Drug Administration.

Mylan said the FDA approved its generic version in 15 milligram, 20 milligram, 30 milligram and 40 milligram doses. U.S. sales of those doses of Zerit, or stavudine, totaled $54 million in the 12 months ended Sept. 30, Mylan said.

The generic is made by Matrix Laboratories Ltd., an Indian company primarily owned by Mylan.

In morning trading, Mylan shares added 14 cents to $9.65. Shares of Bristol-Myers Squibb rose 7 cents to $22.70.


081230
AP081263

Copyright © 2008 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .